US Stock MarketDetailed Quotes
CARA Cara Therapeutics
- 0.310
- +0.005+1.64%
Close Nov 21 16:00 ET
- 0.311
- +0.001+0.32%
Post 18:22 ET
17.01MMarket Cap-177P/E (TTM)
0.315High0.300Low173.67KVolume0.302Open0.305Pre Close53.03KTurnover0.37%Turnover RatioLossP/E (Static)54.86MShares1.31052wk High23.85P/B14.50MFloat Cap0.24052wk Low--Dividend TTM46.79MShs Float29.647Historical High--Div YieldTTM4.92%Amplitude0.240Historical Low0.305Avg Price1Lot Size
Cara Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -47.47%2.56M | -85.71%991K | -65.37%2.14M | -49.92%20.97M | -7.88%3M | -55.00%4.87M | -69.86%6.93M | 28.71%6.17M | 81.81%41.87M | 297.20%3.26M |
| Operating revenue | -73.33%1.3M | --0 | -75.47%1.51M | -51.59%20.27M | -29.32%2.31M | -55.00%4.87M | -69.86%6.93M | 28.71%6.17M | 81.81%41.87M | 297.20%3.26M |
| Cost of revenue | 0 | 0 | -76.06%620K | -15.03%6.17M | -71.46%608K | -49.00%1.56M | 1.42M | 24.46%2.59M | 7.27M | 2.13M |
| Gross profit | -22.73%2.56M | -82.03%991K | -57.62%1.52M | -57.24%14.79M | 111.85%2.4M | -57.36%3.31M | -76.02%5.52M | 31.97%3.58M | 50.26%34.6M | 37.76%1.13M |
| Operating expense | -75.67%7.84M | -58.48%15.72M | -7.83%28.78M | 11.59%136.29M | 7.91%35M | 1.91%32.21M | 37.78%37.86M | 1.98%31.23M | 8.94%122.14M | -5.55%32.44M |
| Selling and administrative expenses | -4.79%6.4M | -15.24%6.37M | -1.11%6.79M | -8.23%27.65M | 2.39%6.55M | -2.27%6.72M | -0.32%7.51M | -26.33%6.86M | 2.88%30.13M | -44.29%6.4M |
| -General and administrative expense | -4.79%6.4M | -15.24%6.37M | -1.11%6.79M | -8.23%27.65M | 2.39%6.55M | -2.27%6.72M | -0.32%7.51M | -26.33%6.86M | 2.88%30.13M | -44.29%6.4M |
| Research and development costs | -94.65%1.36M | -69.29%9.31M | -9.74%21.96M | 18.10%108.51M | 9.25%28.42M | 3.08%25.45M | 52.27%30.31M | 14.39%24.33M | 11.10%91.88M | 13.92%26.01M |
| Depreciation amortization depletion | 135.48%73K | 25.81%39K | 3.45%30K | 1.56%130K | 21.88%39K | -3.13%31K | -3.13%31K | -9.38%29K | 2.40%128K | 0.00%32K |
| -Depreciation and amortization | 135.48%73K | 25.81%39K | 3.45%30K | 1.56%130K | 21.88%39K | -3.13%31K | -3.13%31K | -9.38%29K | 2.40%128K | 0.00%32K |
| Operating profit | 81.73%-5.28M | 54.47%-14.73M | 1.39%-27.27M | -38.80%-121.5M | -4.15%-32.61M | -21.19%-28.9M | -623.17%-32.34M | 0.94%-27.65M | 1.74%-87.54M | 6.61%-31.31M |
| Net non-operating interest income expense | -1.96M | -1.91M | -1.98M | -604K | -604K | 0 | 0 | 0 | 0 | |
| Non-operating interest expense | --1.96M | --1.91M | --1.98M | --604K | --604K | --0 | --0 | --0 | --0 | ---- |
| Other net income (expense) | -704.50%-5.24M | -492.68%-3.38M | -247.11%-1.45M | 73.99%3.59M | -9.71%874K | 30.23%866K | 223.68%861K | 508.02%985K | 221.03%2.06M | 591.43%968K |
| Special income (charges) | ---6M | ---4.07M | ---2.4M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| -Less：Restructuring and merger&acquisition | --707K | --2.58M | --2.4M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| -Less:Impairment of capital assets | --4.27M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Write off | --1.02M | --1.49M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Other non- operating income (expenses) | -11.55%766K | -19.98%689K | -3.35%952K | 73.99%3.59M | -9.71%874K | 30.23%866K | 223.68%861K | 508.02%985K | 221.03%2.06M | 591.43%968K |
| Income before tax | 55.49%-12.48M | 36.41%-20.02M | -15.12%-30.7M | -38.65%-118.51M | -6.59%-32.34M | -20.93%-28.03M | -648.43%-31.48M | 3.91%-26.67M | 3.35%-85.47M | 9.12%-30.34M |
| Income tax | ||||||||||
| Net income | 55.49%-12.48M | 36.41%-20.02M | -15.12%-30.7M | -38.65%-118.51M | -6.59%-32.34M | -20.93%-28.03M | -648.43%-31.48M | 3.91%-26.67M | 3.35%-85.47M | 9.12%-30.34M |
| Net income continuous Operations | 55.49%-12.48M | 36.41%-20.02M | -15.12%-30.7M | -38.65%-118.51M | -6.59%-32.34M | -20.93%-28.03M | -648.43%-31.48M | 3.91%-26.67M | 3.35%-85.47M | 9.12%-30.34M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 55.49%-12.48M | 36.41%-20.02M | -15.12%-30.7M | -38.65%-118.51M | -6.59%-32.34M | -20.93%-28.03M | -648.43%-31.48M | 3.91%-26.67M | 3.35%-85.47M | 9.12%-30.34M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 55.49%-12.48M | 36.41%-20.02M | -15.12%-30.7M | -38.65%-118.51M | -6.59%-32.34M | -20.93%-28.03M | -648.43%-31.48M | 3.91%-26.67M | 3.35%-85.47M | 9.12%-30.34M |
| Basic earnings per share | 55.77%-0.23 | 36.21%-0.37 | -14.29%-0.56 | -37.74%-2.19 | -5.36%-0.59 | -20.93%-0.52 | -625.00%-0.58 | 5.77%-0.49 | 8.62%-1.59 | 11.11%-0.56 |
| Diluted earnings per share | 55.77%-0.23 | 36.21%-0.37 | -14.29%-0.56 | -37.74%-2.19 | -5.36%-0.59 | -20.93%-0.52 | -625.00%-0.58 | 5.77%-0.49 | 8.62%-1.59 | 11.11%-0.56 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data